{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:42:16Z","timestamp":1761709336181},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"French Ministry of Health"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Micron"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.micron.2017.01.009","type":"journal-article","created":{"date-parts":[[2017,2,25]],"date-time":"2017-02-25T04:02:21Z","timestamp":1487995341000},"page":"77-85","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Altered bone microarchitecture and gene expression profile due to calcium deficiency in a mouse model of myeloma"],"prefix":"10.1016","volume":"96","author":[{"given":"H\u00e9l\u00e8ne","family":"Libouban","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Chappard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.micron.2017.01.009_bib0005","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1200\/JCO.2011.36.5726","article-title":"Long-term analysis of the IFM 99 trials for myeloma: cytogenetic abnormalities [t (4; 14), del (17p), 1q gains] play a major role in defining long-term survival","volume":"30","author":"Avet-Loiseau","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.micron.2017.01.009_bib0010","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1200\/JCO.1989.7.12.1909","article-title":"Mechanisms of bone destruction in multiple myeloma: the importance of an unbalanced process in determining the severity of lytic bone disease","volume":"7","author":"Bataille","year":"1989","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.micron.2017.01.009_bib0015","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.morpho.2015.03.002","article-title":"The multiple myeloma bone eco-system and its relation to oncogenesis","volume":"99","author":"Bataille","year":"2015","journal-title":"Morphologie"},{"key":"10.1016\/j.micron.2017.01.009_bib0020","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1210\/jc.2013-1274","article-title":"Consumption of yogurts fortified in vitamin D and calcium reduces serum parathyroid hormone and markers of bone resorption: a double-blind randomized controlled trial in institutionalized elderly women","volume":"98","author":"Bonjour","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.micron.2017.01.009_bib0025","doi-asserted-by":"crossref","first-page":"e41127","DOI":"10.1371\/journal.pone.0041127","article-title":"Soluble rank ligand produced by myeloma cells causes generalised bone loss in multiple myeloma","volume":"7","author":"Buckle","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.micron.2017.01.009_bib0030","series-title":"Bone Cancer: Progression and Therapeutic Approaches","first-page":"111","article-title":"Technical aspects: how do we best prepare bone samples for proper histological analysis?","author":"Chappard","year":"2014"},{"issue":"Suppl. 1","key":"10.1016\/j.micron.2017.01.009_bib0035","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/ijlh.12360","article-title":"Advances in the pathogenesis and diagnosis of multiple myeloma","volume":"37","author":"Chesi","year":"2015","journal-title":"Int. J. Lab. Hematol."},{"key":"10.1016\/j.micron.2017.01.009_bib0040","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1182\/blood.V96.2.671","article-title":"Macrophage inflammatory protein 1-alpha is a potential osteoclast stimulatory factor in multiple myeloma","volume":"96","author":"Choi","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.micron.2017.01.009_bib0045","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1359\/jbmr.2003.18.3.482","article-title":"Zoledronic acid treatment of 5T2MM-bearing mice inhibits the development of myeloma bone disease: evidence for decreased osteolysis, tumor burden and angiogenesis, and increased survival","volume":"18","author":"Croucher","year":"2003","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.micron.2017.01.009_bib0050","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1038\/leu.2009.121","article-title":"The effects of JNJ-26481585, a novel hydroxamate-based histone deacetylase inhibitor, on the development of multiple myeloma in the 5T2MM and 5T33MM murine models","volume":"23","author":"Deleu","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.micron.2017.01.009_bib0055","doi-asserted-by":"crossref","first-page":"5307","DOI":"10.1158\/0008-5472.CAN-08-4472","article-title":"Bortezomib alone or in combination with the histone deacetylase inhibitor JNJ-26481585: effect on myeloma bone disease in the 5T2MM murine model of myeloma","volume":"69","author":"Deleu","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.micron.2017.01.009_bib0060","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1182\/blood-2005-03-1080","article-title":"IL-3 is a potential inhibitor of osteoblast differentiation in multiple myeloma","volume":"106","author":"Ehrlich","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.micron.2017.01.009_bib0065","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/jn\/129.1.188","article-title":"Calcium-regulating hormones, bone mineral content, breaking load and trabecular remodeling are altered in growing pigs fed calcium-deficient diets","volume":"129","author":"Eklou-Kalonji","year":"1999","journal-title":"J. Nutr."},{"key":"10.1016\/j.micron.2017.01.009_bib0070","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0140-6736(09)60507-9","article-title":"Hyperparathyroidism","volume":"374","author":"Fraser","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.micron.2017.01.009_bib0075","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1002\/1097-0142(20000615)88:12+<2892::AID-CNCR2>3.0.CO;2-Y","article-title":"Molecular mechanisms of osteolytic bone metastases","volume":"88","author":"Guise","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.micron.2017.01.009_bib0080","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1210\/jcem.86.8.7783","article-title":"Secondary hyperparathyroidism and bone turnover in elderly blacks and whites","volume":"86","author":"Harris","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.micron.2017.01.009_bib0085","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1182\/blood-2006-09-048686","article-title":"Granulocyte colony-stimulating factor enhances bone tumor growth in mice in an osteoclast-dependent manner","volume":"109","author":"Hirbe","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.micron.2017.01.009_bib0090","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1538\/expanim.53.347","article-title":"Response of cortical and cancellous bones to mild calcium deficiency in young growing female rats: a bone histomorphometry study","volume":"53","author":"Iwamoto","year":"2004","journal-title":"Exp. Anim."},{"key":"10.1016\/j.micron.2017.01.009_bib0095","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1083\/jcb.200201089","article-title":"Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor","volume":"157","author":"Kato","year":"2002","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.micron.2017.01.009_bib0100","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S8756-3282(03)00196-0","article-title":"Increased bone remodeling due to ovariectomy dramatically increases tumoral growth in the 5T2 multiple myeloma mouse model","volume":"33","author":"Libouban","year":"2003","journal-title":"Bone"},{"key":"10.1016\/j.micron.2017.01.009_bib0105","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.bbrc.2004.02.131","article-title":"Selection of a highly aggressive myeloma cell line by an altered bone microenvironment in the C57BL\/KaLwRij mouse","volume":"316","author":"Libouban","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.micron.2017.01.009_bib0110","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.morpho.2015.01.003","article-title":"The use of animal models in multiple myeloma","volume":"99","author":"Libouban","year":"2015","journal-title":"Morphologie"},{"key":"10.1016\/j.micron.2017.01.009_bib0115","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1210\/edrv.22.4.0437","article-title":"Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications","volume":"22","author":"Lips","year":"2001","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.micron.2017.01.009_bib0120","first-page":"27","article-title":"Disuse induced by botulinum toxin affects the bone marrow expression profile of bone genes leading to a rapid bone loss","volume":"13","author":"Marchand-Libouban","year":"2013","journal-title":"J. Musculoskelet. Neuronal Interact."},{"key":"10.1016\/j.micron.2017.01.009_bib0125","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1007\/s00198-004-1828-6","article-title":"Consumption of a high calcium mineral water lowers biochemical indices of bone remodeling in postmenopausal women with low calcium intake","volume":"16","author":"Meunier","year":"2005","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.micron.2017.01.009_bib0130","first-page":"98","article-title":"Unwrapping microcomputed tomographic images for measuring cortical osteolytic lesions in the 5T2 murine model of myeloma treated by bisphosphonate","volume":"68","author":"N'Diaye","year":"2015","journal-title":"Micron"},{"key":"10.1016\/j.micron.2017.01.009_bib0135","doi-asserted-by":"crossref","first-page":"E784","DOI":"10.1152\/ajpendo.00029.2005","article-title":"IL-6 is not required for parathyroid hormone stimulation of RANKL expression, osteoclast formation, and bone loss in mice","volume":"289","author":"O'Brien","year":"2005","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.micron.2017.01.009_bib0140","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.exphem.2004.11.015","article-title":"MIP-1alpha utilizes both CCR1 and CCR5 to induce osteoclast formation and increase adhesion of myeloma cells to marrow stromal cells","volume":"33","author":"Oba","year":"2005","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.micron.2017.01.009_bib0145","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.bone.2010.07.012","article-title":"Vitamin D deficiency promotes growth of MCF-7 human breast cancer in a rodent model of osteosclerotic bone metastasis","volume":"47","author":"Ooi","year":"2010","journal-title":"Bone"},{"key":"10.1016\/j.micron.2017.01.009_bib0150","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.bone.2015.04.004","article-title":"A review of current murine models of multiple myeloma used to assess the efficacy of therapeutic agents on tumour growth and bone disease","volume":"77","author":"Paton-Hough","year":"2015","journal-title":"Bone"},{"key":"10.1016\/j.micron.2017.01.009_bib0155","doi-asserted-by":"crossref","first-page":"11581","DOI":"10.1073\/pnas.201394498","article-title":"Multiple myeloma disrupts the TRANCE\/osteoprotegerin cytokine axis of trigger bone destruction and promote tumor progression","volume":"98","author":"Pearse","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.micron.2017.01.009_bib0160","doi-asserted-by":"crossref","first-page":"e15233","DOI":"10.1371\/journal.pone.0015233","article-title":"Consequences of daily administered parathyroid hormone on myeloma growth, bone disease, and molecular profiling of whole myelomatous bone","volume":"5","author":"Pennisi","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.micron.2017.01.009_bib0165","doi-asserted-by":"crossref","first-page":"609","DOI":"10.4049\/jimmunol.122.2.609","article-title":"Idiopathic paraproteinemia II: Transplantation of the paraprotein-producing clone from old to young C57BL\/KaLwRij mice","volume":"122","author":"Radl","year":"1979","journal-title":"J. Immunol."},{"key":"10.1016\/j.micron.2017.01.009_bib0170","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1002\/1097-0142(19850301)55:5<1030::AID-CNCR2820550518>3.0.CO;2-Y","article-title":"Influence of treatment with APD-bisphosphonate on the bone lesions in the mouse 5T2 multiple myeloma","volume":"55","author":"Radl","year":"1985","journal-title":"Cancer"},{"key":"10.1016\/j.micron.2017.01.009_bib0175","first-page":"177","article-title":"Animal model of human disease: multiple myeloma","volume":"132","author":"Radl","year":"1988","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.micron.2017.01.009_bib0180","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/leu.2008.336","article-title":"Pathogenesis of myeloma bone disease","volume":"23","author":"Roodman","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.micron.2017.01.009_bib0185","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s00774-009-0154-7","article-title":"Targeting the bone microenvironment in multiple myeloma","volume":"28","author":"Roodman","year":"2010","journal-title":"J. Bone Miner. Metab."},{"key":"10.1016\/j.micron.2017.01.009_bib0190","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1002\/cncr.22991","article-title":"Pathologic fractures correlate with reduced survival in patients with malignant bone disease","volume":"110","author":"Saad","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.micron.2017.01.009_bib0195","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S8756-3282(99)00229-X","article-title":"Trabecular bone turnover, bone marrow cell development, and gene expression of bone matrix proteins after low calcium feeding in rats","volume":"25","author":"Seto","year":"1999","journal-title":"Bone"},{"key":"10.1016\/j.micron.2017.01.009_bib0200","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1182\/blood-2006-07-034884","article-title":"HGF inhibits BMP-induced osteoblastogenesis: possible implications for the bone disease of multiple myeloma","volume":"109","author":"Standal","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.micron.2017.01.009_bib0205","series-title":"Systat\u00ae 13, Statistics I II III IV","author":"Systat","year":"2009"},{"key":"10.1016\/j.micron.2017.01.009_bib0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/ejh.12205","article-title":"Smoldering multiple myeloma: present position and potential promises","volume":"92","author":"Tageja","year":"2014","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.micron.2017.01.009_bib0215","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1056\/NEJMoa030847","article-title":"The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma","volume":"349","author":"Tian","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.micron.2017.01.009_bib0220","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/leu.2011.43","article-title":"A novel role for CCL3 (MIP-1alpha) in myeloma-induced bone disease via osteocalcin downregulation and inhibition of osteoblast function","volume":"25","author":"Vallet","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.micron.2017.01.009_bib0225","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1054\/bjoc.1999.1024","article-title":"Selective initial in vivo homing pattern of 5T2 multiple myeloma cells in the C57BL\/KaLwRij mouse","volume":"82","author":"Vanderkerken","year":"2000","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.micron.2017.01.009_bib0230","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.pbiomolbio.2016.08.003","article-title":"Myeloma bone disease: progress in pathogenesis","volume":"122","author":"Xi","year":"2016","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"10.1016\/j.micron.2017.01.009_bib0235","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.bone.2014.06.006","article-title":"Osteocyte-derived RANKL is a critical mediator of the increased bone resorption caused by dietary calcium deficiency","volume":"66","author":"Xiong","year":"2014","journal-title":"Bone"},{"key":"10.1016\/j.micron.2017.01.009_bib0240","doi-asserted-by":"crossref","first-page":"9542","DOI":"10.1158\/0008-5472.CAN-07-1046","article-title":"Accelerated bone resorption, due to dietary calcium deficiency, promotes breast cancer tumor growth in bone","volume":"67","author":"Zheng","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.micron.2017.01.009_bib0245","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s10585-008-9172-4","article-title":"Bone resorption increases tumour growth in a mouse model of osteosclerotic breast cancer metastasis","volume":"25","author":"Zheng","year":"2008","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.micron.2017.01.009_bib0250","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/pros.21316","article-title":"Vitamin D deficiency promotes prostate cancer growth in bone","volume":"71","author":"Zheng","year":"2011","journal-title":"Prostate"}],"container-title":["Micron"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968432816302529?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968432816302529?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T10:58:27Z","timestamp":1692701907000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968432816302529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":50,"alternative-id":["S0968432816302529"],"URL":"https:\/\/doi.org\/10.1016\/j.micron.2017.01.009","relation":{},"ISSN":["0968-4328"],"issn-type":[{"value":"0968-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Altered bone microarchitecture and gene expression profile due to calcium deficiency in a mouse model of myeloma","name":"articletitle","label":"Article Title"},{"value":"Micron","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micron.2017.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}